<code id='8FEADE3873'></code><style id='8FEADE3873'></style>
    • <acronym id='8FEADE3873'></acronym>
      <center id='8FEADE3873'><center id='8FEADE3873'><tfoot id='8FEADE3873'></tfoot></center><abbr id='8FEADE3873'><dir id='8FEADE3873'><tfoot id='8FEADE3873'></tfoot><noframes id='8FEADE3873'>

    • <optgroup id='8FEADE3873'><strike id='8FEADE3873'><sup id='8FEADE3873'></sup></strike><code id='8FEADE3873'></code></optgroup>
        1. <b id='8FEADE3873'><label id='8FEADE3873'><select id='8FEADE3873'><dt id='8FEADE3873'><span id='8FEADE3873'></span></dt></select></label></b><u id='8FEADE3873'></u>
          <i id='8FEADE3873'><strike id='8FEADE3873'><tt id='8FEADE3873'><pre id='8FEADE3873'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:8
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          New safety details link Apellis eye drug to rare cases of blindness
          New safety details link Apellis eye drug to rare cases of blindness

          AdobeFiveelderlypeoplehavebeenblindedinoneeyebyaseveresideeffectafterreceivinginjectionsofanewlyappr

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          The biotech scorecard for the 2nd quarter: 12 industry events to watch

          APStockIntroducingSTAT’sBiotechQ2Scorecard,ouremoji-enabledmeansoftracking12make-or-breakeventsexpec